China's Shanghai Fosun Pharmaceutical-backed Gland Pharma is expected to launch its initial public offering next week, the people familiar with the development told Moneycontrol
China has suspended Ant Group's blockbuster IPO in Shanghai and Hong Kong just before its scheduled listing on November 5, citing major issues. Watch the video to find out what has happened so far
In a big relief for the cinema business, the Maharashtra government has allowed theatres to re-open from November 5
Ajay Singh, chairman & managing director, SpiceJet, has proved before that he can rewrite SpiceJet's trajectory. He's now looking to tap into existing revenue streams beyond passenger flights to keep the airline afloat—but the pandemic may not be the only headwind blowing its way
While the Russian Sputnik V vaccine follows a similar path as the Oxford-Astrazeneca vaccine of being based on the human adenovirus, a common cold virus fused with the spike protein of Sars-Cov-2 to stimulate an immune response, its approval and registration without the crucial Phase III trial and consequent tie-up with Dr Reddy's Laboratories has made headlines. Manu Balachandran, author of this fortnight's cover story delves into GV Prasad and Dr Reddy's long-standing relationship with Russia, the country's apparent transparency with the pharma company, and why it bet on
For the first time since the March lockdown, the government has permitted restaurants and bars to open shop. Here's how they are ensuring employee and customer safety
Build. Scale. Repeat: Ronnie Screwvala, who transformed UTV from a production company to a multimedia conglomerate, is now dipping into his entrepreneurial genius to build edtech startup upGrad into a venture of scale and impact. Can it compete with the likes of Byju's and Unacademy?
India is planning to bring in a law to ban trade in cryptocurrency, that will certainly come as a huge blow to an industry that has been booming during the lockdown
The first NYFW of the pandemic was a mix of virtual and physical shows, with a limited audience, social distancing, and some reimagined mask couture
By building new capabilities in digital, cloud, automation and AI, Infosys has won ever larger contracts. And the share of revenues from digital technology services as a proportion of the total has almost doubled in the last two years, to 45 percent.. Cover story author Harichandan Arakali speaks about the 'Salil Parekh flavour', the impact of H-1B visa restrictions on Infosys, and takes stock of the CEO and MD's biggest challenge yet: Ensuring the company stays on course